Balanced Risk Amid Regulatory Overhang: Why Sean Dodge Maintains a Hold on Addus Despite Solid Operational Execution

Analyst Sean Dodge of BMO Capital maintained a Hold rating on Addus Homecare, retaining the price target of $120.00.

Sean Dodge has given his Hold rating due to a combination of factors tied to both operational progress and regulatory uncertainty. He acknowledges that Addus is executing well on key initiatives—such as expanding caregiver capacity, benefiting from state rate increases, and leveraging its caregiver app and clinical integration to drive growth in personal care and hospice—but notes that these positives are unfolding against a challenging policy backdrop.

He points out that looming Medicaid reimbursement changes, delays around the 80/20 Access Rule, and pressure on Home Health rates create a persistent overhang on valuation, even as the company appears positioned for continued double-digit EBITDA expansion through organic growth and acquisitions. As a result, he views the risk‑reward as balanced at current levels and indicates he would likely turn more constructive either if the regulatory environment becomes clearer and less threatening, or if the stock pulls back to a more compelling entry point.